Lorenz Muller - 21 Mar 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Commercial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 21:46:14 UTC
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Employee Stock Option Grant (right to buy) Award $0 +160,000 $0.000000 160,000 21 Mar 2022 Common Shares 160,000 $5.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.